estrofem 2 mg
novo nordisk ltd., israel - estradiol as hemihydrate - film coated tablets - estradiol as hemihydrate 2 mg - estradiol - estradiol - hormone replacement therapy (hrt) for estrogen deficiency symptoms in postmenopausal women. prevention of osteoporosis in postmenopausal women at high risk of future fractures, who are tolerant of , or contraindicated for other medicinal products approved for the prevention of osteoporosis. estrofem is particularly for women who have been hysterectomized and therefore do not require combined estrogen/progestagen therapy.the experience treating women older than 65 years is limited.
estrofem 1 mg
novo nordisk ltd., israel - estradiol as hemihydrate - film coated tablets - estradiol as hemihydrate 1 mg - estradiol - estradiol - hormone replacement therapy (hrt) for estrogen deficiency symptoms in postmenopausal women. prevention of osteoporosis in postmenopausal women at high risk of future fractures, who are tolerant of , or contraindicated for other medicinal products approved for the prevention of osteoporosis. estrofem is particularly for women who have been hysterectomized and therefore do not require combined estrogen/progestagen therapy.the experience treating women older than 65 years is limited.
rybelsus 14 mg
novo nordisk ltd., israel - semaglutide - tablets - semaglutide 14 mg - semaglutide - rybelsus is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus to improve glycaemic control as an adjunct to diet and exercise• as monotherapy when metformin is considered inappropriate due to intolerance or contraindications• in combination with other medicinal products for the treatment of diabetes.
rybelsus 3 mg
novo nordisk ltd., israel - semaglutide - tablets - semaglutide 3 mg - semaglutide - rybelsus is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus to improve glycaemic control as an adjunct to diet and exercise• as monotherapy when metformin is considered inappropriate due to intolerance or contraindications• in combination with other medicinal products for the treatment of diabetes.
rybelsus 7 mg
novo nordisk ltd., israel - semaglutide - tablets - semaglutide 7 mg - semaglutide - rybelsus is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus to improve glycaemic control as an adjunct to diet and exercise• as monotherapy when metformin is considered inappropriate due to intolerance or contraindications• in combination with other medicinal products for the treatment of diabetes.
novofem tablets
novo nordisk ltd - not applicable
novomix 30 penfill 100unitsml suspension for injection 3ml cartridges
novo nordisk ltd - insulin aspart; insulin aspart protamine - suspension for injection - 30unit/1ml ; 70unit/1ml
novorapid penfill 100unitsml solution for injection 3ml cartridges
novo nordisk ltd - insulin aspart - solution for injection - 100unit/1ml
novorapid 100unitsml solution for injection 10ml vials
novo nordisk ltd - insulin aspart - solution for injection - 100unit/1ml
novorapid flexpen 100unitsml solution for injection 3ml pre-filled pen
novo nordisk ltd - insulin aspart - solution for injection - 100unit/1ml